companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2023

CVR: 38231170

Source: annual report 2023, Danish Business Authority

01/04/2022 – 31/03/2023

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,429,726 and a net result of DKK -13,930,313 compared with DKK -10,898,671 the year before. Equity in the 2023 report amounted to DKK -32,905,229. The company had 6 employees in the financial year.

Gross Profit
DKK -9,429,726
Profit/Loss
DKK -13,930,313
Equity
DKK -32,905,229
Total Assets
DKK 15,287,951
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--9.4M-13.9M-32.9M6
20220-7.2M-10.9M-19M3
2021-1.4M-1.9M8.2M3
2020-839K-1.6M10.1M2
2019-296K-1.1M11.7M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Marie Allen Schroeder joins the board of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Marie Allen Schroeder has joined the board of directors of Hoba Therapeutics ApS.

Gonçalo Nuno Nunes da Silva Rebelo de Andrade joins the board of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Gonçalo Nuno Nunes da Silva Rebelo de Andrade has joined the board of directors of Hoba Therapeutics ApS.

Teit Eliot Johansen leaves the board of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Teit Eliot Johansen has left the board of directors of Hoba Therapeutics ApS.

Morten Døssing leaves the board of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Morten Døssing has left the board of directors of Hoba Therapeutics ApS.

Novo Holdings A/S registered as owner of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Novo Holdings A/S is registered as an owner of Hoba Therapeutics ApS with an ownership share of 33%.

Danmarks Eksport- og Investeringsfond registered as owner of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, Danmarks Eksport- og Investeringsfond is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.

Registered as owner of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.

Registered as owner of Hoba Therapeutics ApSDec 8, 2023

As of December 8, 2023, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 5%.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority